key: cord-0929533-rbmakz68
authors: Marone, Enrico M.; Rinaldi, Luigi F.
title: Upsurge of deep venous thrombosis in patients affected by COVID-19: preliminary data and possible explanations
date: 2020-04-17
journal: J Vasc Surg Venous Lymphat Disord
DOI: 10.1016/j.jvsv.2020.04.004
sha: 05ca33c7575e5475279916d3dc7c28b8534cdda7
doc_id: 929533
cord_uid: rbmakz68

nan

It is known that hospitalized, bedridden patients are particularly prone to develop deep venous 3 thrombosis (DVT), whose overall incidence among in-hospital patients is 0.9%, rising up to 15-4 32% among intensive care unit (ICU) patients in absence of adequate prophylaxis. 1,2 However, 5 over the last month, a remarkable increase in the diagnoses of DVT has been noticed among non-6 ICU hospitalized patients as well, due to the numerous cases of DVT observed among infected 7 each other and whether how they affect the chance of recovery. However, considering these 10 preliminary data, our Institution is starting to administrate anticoagulant doses of low-molecular 11 weight heparin in hospitalized COVID-19 patients, after monitoring coagulation tests, kidney 12 and liver functions. 13

In conclusion, DVT can be considered as a frequent and potentially lethal complication of 14 COVID-19, which deserves further attention in order to establish incidence, mortality rate and 15 the opportunity of a screening program and prophylactic therapy in this kind of patients. 16

Assessing the Risk for Development of Deep Vein 2 Thrombosis among Chinese Patients using the

VTE in the ICU Workshop Participants

Prevalence, incidence, and risk factors for venous thromboembolism in medical-surgical 7 intensive care unit patients

Empirical systemic 9 anticoagulation is associated with decreased venous thromboembolism in critically ill influenza

A H1N1 acute respiratory distress syndrome patients

Prevalence and 13 significance of coagulation abnormalities in community-acquired pneumonia